(VTAK) FORT MILL, S.C., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced that September 10th, 2025, is the Record Date for the October 10th Special Meeting of the stockholders. We are seeking stockholder approval to amend our Certificate of Incorporation to increase our authorized shares of common stock, and to appoint WithumSmith+Brown, PC as our independent auditor for our fiscal year 2026. Additional details are available in the preliminary proxy statement anticipated to be filed with the SEC on September 4th, 2025.
Related Questions
Will the authorized share increase dilute existing shareholders and affect the stock’s valuation?
How might appointing a new independent auditor influence investor confidence and future financial disclosures?
What is the expected market reaction to the special meeting and record date, and are there any anticipated proxy voting trends?